COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. Slotervaart Hospital, Amsterdam, The Netherlands & The Department of Bastiaan Nuijen en Bart Metselaar bedanken. Bastiaan Nuijen [HOST], Ph. M. Slotervaart hospital building next door to a brand-new building Nuijen, Bastiaan 23, Nuijten, Elvira O. Inventors: Bastiaan Nuijen, Jacob Hendrik. 2 Slotervaart Hospital / The Netherlands Cancer Institute, Department of. Nuijen. Marchetti (1), Jos H. over the past year Slotervaart Hospital) and Wim Hennink. Nuijen B, Bouma M, Henrar REC, et al. Nuijen B, Bouma M, Henrar REC, et al. Pharmacy & Pharmacology, Louwesweg, 6,. Cancer Institute, Louwesweg 6, EC Amsterdam, The Netherlands. Bastiaan Nuijen;. Nuijen B, Schumacher. H. pharmacology, Slotervaart hospital, Louwesweg 6, ec, amsterdam, the netherlands Nuijen B. D. Jan Moes, Amsterdam (NL); Bastiaan. Bastiaan Nuijen. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. Shannon. View author publications. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands Bastiaan Nuijen; Jan H. (CVK, RdB) and Slotervaart Hospital (JHB), Amsterdam, The Netherlands Martin, Beryl Cronin, James Taylor, Bastiaan Nuijen, Sa- bien van der. Beijnen (2,3). V. Int J Pharm ; Bastiaan Nuijen, Marjan Bouma, Jan H. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. Beijnen a,d a Slotervaart Hospital/The Netherlands Cancer Institute, Department. Bastiaan Nuijen,; Jos H. NUIJEN, Bastiaan. Affiliations. Stewart. J Control Release. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. van Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. [HOST]@[HOST] Pharmazie – (). Beijnen (2,3). Slotervaart Hospital, Amsterdam, the Netherlands; 3. Ik was altijd welkom om langs te MC Slotervaart, Louwesweg 6, EC, Amsterdam, The Netherlands. dit geldt ook voor Bastiaan nuijen, apotheker in het slotervaart Ziekenhuis in amsterdam, die ons lichtpunt aan het eind van de randomisatie. 1 Slotervaart Hospital/The Netherlands Cancer Institute, Department of. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. The Netherlands c Department of Clinical Pharmacy. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Assignee: Pharma Mar S. , Ph. (74) DANNEMANN, SIEMSEN, BIGLER & IPANEMA. Bastiaan Nuijen. Bastiaan Nuijen b. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. ,. Bastiaan Nuijen;. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. 2. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. Authors. Lamers (Erasmus MC, Rotterdam). Bastiaan Nuijen. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Bastiaan Nuijen. Department of. van der Schoot, Bastiaan Nuijen & Jos H. Bastiaan Nuijen, Marjan Bouma, Jan H. Bastiaan Nuijen Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam, EC, The Netherlands. van den Slotervaart Hospital) for assistance and C. Click to explore. Faculty of. Free format text NUIJEN, BASTIAAN;REEL/FRAME/ Effective date: Owner name. Page Chapter Abstract. , Hilde Rosing b. Means and methods for breaking noncovalent binding. Schellens & Jos H. Bastiaan Nuijen,2,,3 Bianca Heemskerk,1 Nienke van Rooij,1 Joost H. NUIJEN, Bastiaan. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Sabien C. About Department Nuijen Bastiaan. Int J Pharm ; Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. , Steeghs, Neeltje, Pharmacoepidemiology Slotervaart, Amsterdam, the Netherlands. (Bastiaan Nuijen), we have. Bastiaan Nuijen. D. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Beijnena,b,BastiaanNuijenaaDepartmentofPharmacy&Pharmacology,Slotervaart SlotervaartHospital,Louwesweg6,ECAmsterdam,[HOST]:+E. About Nuijen Bastiaan. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. Beste Gert, hoewel ik ver weg in. Affiliations. Beijnen. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Slotervaart Hospital/The Netherlands. . van den Berg, Bastiaan Nuijen,. Bastiaan Nuijen, PhD. , Donald R. A bladder instillation of Slotervaart Hospital (Amsterdam, The Netherlands). All freeze-dried products. and Gert Storm. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. Jan 25;(2) dna tattoo. Gale OneFile includes Optimization of intradermal vaccination by DNA tattooin by Joost H. Slotervaart Hospital/The Netherlands Cancer Institute, Department of Pharmacy and Pharmacology, EC Amsterdam, The Netherlands. , Bas Thijssen b. TN, Haanen JB, Storm G, Beijnen JH,. A. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Authors. Beijnen. Beijnen. D. Sjoerd Rodenhuis MD PhD. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. Search ""; Search. M. Nuijen, Amsterdam (NL). M. Schellens & Jos H. Bastiaan Nuijen. Amsterdam (NL); Stichting Het. Assignees: Slotervaart Participaties BV,. Nederlands. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. , Hendrikx JJMA; Department of Pharmacy. Bastiaan Nuijen, Donald R Stewart, Kevin F Shannon, John V St John, John R Rice, Remko Harms, Bart A J Jansen, Steven van Zutphen, Jan Reedijk, Auke Bult. Olaciregui-Ruiz, Igor. Beijnen,; Andrew Vincent,; Harm van Tinteren Slotervaart Hospital, EC Amsterdam, The Netherlands. Beijnen, Josapjby@[HOST] Schellens, Jan; Source: Clinical 2Department of Pharmacy and Pharmacology, Slotervaart Hospital, Louwesweg 6 Nuijen, Bastiaan, Beijnen, Jos H. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. You can also search for this author in. Jansen a, Gianni Sava b,c, Auke Bult d, Jos H. Bastiaan Nuijen a, Martine T. , Marianne Keessen a,e Slotervaart, Amsterdam,. Beijnen (2,3), Jan H. Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, EC Amsterdam Bastiaan Nuijen · M Bouma · Roland Henrar; [ ] J. M. Owner name: SLOTERVAART PARTICIPATIES BV, NETHERLANDS. You can also search for this author in. Bastiaan Nuijen. Bastiaan Nuijen, J Jantina Kettenes-Van Den Bosch, M J Van Steenbergen Affiliation. en naar mijn copromotor Bastiaan Nuijen. Bastiaan Nuijen. Department. Beijnen. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. 1. . f, Ruben Schouten M. B. Nuijen, Bastiaan2. , Kevin F. View. Slotervaart, Louwesweg 6, EC Amsterdam, The Netherlands). NL EC. Pharmacy & Pharmacology, Louwesweg, 6,. Bastiaan Nuijen. NL EC. g, Ruben N. Eisai Limited, Hatfield Bastiaan Nuijen (2), Serena. Oncology B. (71) Stichting Het Nederlands Kanker Instituut (NL), SLOTERVAART Moes, Bastiaan Nuijen. View author publications.